Dual-Action Intraocular Pressure Control for Glaucoma Management

Opthocare XT is an advanced combination ophthalmic solution containing Dorzolamide Hydrochloride 2% w/v and Timolol Maleate 0.5% w/v, specifically designed to deliver effective and sustained reduction of intraocular pressure (IOP) in pets diagnosed with early-stage to progressive glaucoma.

By pairing a carbonic anhydrase inhibitor (Dorzolamide) with a beta-blocker (Timolol), this solution provides synergistic IOP control, reducing aqueous humor production while enhancing fluid outflow. This dual mechanism prevents optic nerve damage, slows disease progression, and preserves vision—making Opthocare XT a cornerstone therapy for veterinary glaucoma care.

📦 Available Variants & Dosage Specifications

Opthocare XT is offered in a single optimized formulation:

✔️ Dorzolamide Hydrochloride 2% + Timolol Maleate 0.5%

This combination has been clinically proven to:

• Deliver more effective IOP reduction than monotherapy

• Provide rapid pressure stabilization

• Offer long-term glaucoma control without dosing complexity

A single variation ensures accuracy, consistency, and convenience for veterinarians and pet owners while minimizing confusion in chronic glaucoma treatment.

🔬 Scientific Insights Behind the Product

⭐ 1. Dual Mechanism for Effective IOP Reduction

• Dorzolamide 2% inhibits carbonic anhydrase in the ciliary body → reduces aqueous humor formation.

• Timolol 0.5% decreases aqueous production and enhances outflow via beta-blockade.

Together, they provide a powerful synergistic effect, lowering IOP more effectively than either agent alone.

⭐ 2. Targeted Control Across IOP Stages

Opthocare XT reliably lowers pressure across clinically relevant IOP stages:

• Maintains normal ranges

• Reduces pressure in mild to moderate glaucoma

• Helps stabilize severe cases when used alongside other therapies

This makes it a versatile and essential therapy for progressive glaucoma management.

⭐ 3. Vision Preservation Through Optic Nerve Protection

Chronic elevated IOP leads to irreversible optic nerve damage.
Opthocare XT helps:

• Slow down optic nerve degeneration

• Preserve vision for longer

• Minimize pain and discomfort associated with glaucoma

Its dual-action formula ensures better long-term ocular health and superior treatment outcomes.

🌟 Why Opthocare XT Is the Ideal Glaucoma Therapy

• Strong, consistent reduction of intraocular pressure

• Synergistic dual-drug advantage over monotherapy

• Safe and effective for dogs and cats

• Ideal for early-stage glaucoma and long-term management

• Single, precisely formulated variant for easy dosing

Shipping Policy
We offer free standard shipping on orders above ₹[set amount] within Hyderabad.

• Within 5 km: 20–30 mins delivery

• 5–15 km: 1–2 hours

• 15–30 km: 2–4 hours

• Outside Hyderabad: 3–5 business days

Delivery timelines may vary due to traffic, weather, or other factors. Tracking details will be shared once the order is dispatched.

Returns & Cancellations
Returns are accepted within 2 days of delivery for unused, unopened products in original packaging with proof of purchase.

• Non-returnable items: Opened pet food, perishable products, clearance items, or custom orders.

• Damaged or wrong item? Contact us within 24–48 hours for a free replacement or refund.

• Refunds: Processed in 2–3 business days after we receive the product.

Orders can be canceled before dispatch only.

Read more about Shipping & Delivery Policy